HPS-182 - Investigating the suspected drugs associated with drug-induced liver injury and evaluating the use of hepatoprotective drug use as a treatment: a single-centre retrospective study

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: HPS-182
• By: LIU, Ying (Kiang Wu Hospital, China)
• Co-author(s): Ying Liu (Kiang Wu Hospital, Macau, China / University of Macau, Macau, China)
  Yongjia Liang (Kiang Wu Hospital, Macau, China)
  Mankeong Chan (Kiang Wu Hospital, Macau, China)
  Kifung Chang (Kiang Wu Hospital, Macau, China)
  Jiayue Gan (Kiang Wu Hospital, Macau, China)
  Hailun Li (Kiang Wu Hospital, Macau, China)
  Sut leng Lei (Kiang Wu Hospital, Macau, China)
  
• Abstract:

  Background
  Drug-induced liver injury (DILI) refers to a liver injury caused by various medications, herbs, or other xenobiotics leading to abnormalities in the liver or liver dysfunction with the reasonable exclusion of other etiologies. Drug-induced liver injury is a rare adverse drug reaction which can lead to liver failure and even death. The..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login